Compare Medtronic PLC (MDT) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Verizon Communications Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Verizon Communications Inc trades at $41.65 (market cap $192.57B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.11%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Verizon Communications Inc for 109 Days on average.
| MDT | VZ | |
|---|---|---|
Market Cap | $112.24B | $192.57B |
Volume | 105,663,236 | 20,940,094 |
Sector | Health | Media |
52-Week High | $105.35 | $51.45 |
52-Week Low | $73.75 | $38.40 |
Typical Hold Time | 63 Days | 109 Days |
Enterprise Value | $131.58B | $379.28B |
Dividend Yield | 3.28% | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
Verizon (VZ) trades at $46.35, up 1.27% today, with a bearish technical signal but strong fundamentals including a P/E of 12.07 and net income margin of 11.64%. Recent earnings beats and a $0.71 dividend highlight stability, while cash flow improved to $14.86B in 2025. The stock is near its consensus price target of $48.17, with analyst sentiment mixed but leaning hold.
Outlook: Verizon offers value with steady dividends and cash flow, but faces competition and debt risks. Upside depends on execution in wireless markets; cautious optimism is warranted given technical weakness and modest growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
